Benefits & Events

Over the course of an hour, we will dive into the many manifestations of ocular tumors, starting with orbital tumors. Orbital tumors are one of most commonly initially missed ophthalmic diseases seen in clinical practice by Oculoplastic Surgeons. Oculoplastic Surgeon, Dr. Chris Thiagarajah will perform a review of orbital tumors, what to look for, how to diagnose, and key findings. Ocular Oncologist, Dr. Peter Hovland, will then spend the last half of the course presenting an overview of intraocular tumors, exploring eye cancer diagnosis based on patient history and examination, and diagnostic imaging (widefield photography and angiography, ultrasonography, and optical coherence tomography (OCT). By seeking early detection of orbital and intraocular tumors, optometrists and ophthalmologists assist in providing better treatments with lower morbidity and mortality.

PRESENTERS: Peter Hovland, MD, PhD - Ocular Oncologist/Vitreoretinal Specialist at Colorado Retina Associates & Christopher Thiagarajah, MD, FACS - Oculoplastic Surgeon at Park Avenue Oculoplastics

‍

Uveitis, a general, yet highly complex term for a group of inflammatory diseases with no one size-fits all description, responsible for between 10-15 percent of all cases of blindness in the US. Caused by inflammatory responses, uveitis is not just limited to the uvea, having the potential to wreak havoc throughout the eye and in other parts of the body.

Colorado Retina's uveitis gurus, Dr. Mark Dacey and Dr. Ashleigh Levison, over the course of an hour will explore a variety of uveitis manifestations, underlying systemic diseases, presentation patterns and symptoms, the lengthy road to proper diagnosis, current treatment options, and the vision-threatening implications these diseases can have for patients. Dr. Dacey and Dr. Levison will also cover a few of their most peculiar cases that are not to be missed.

‍

Colorado Retina & Mile High Eye Institute teamed up to review Optical Coherence Tomography (OCT), an emerging technology for performing high-resolution cross-sectional optical imaging.

Dr. Zak Vest, of MHEI and Dr. Brian Joondeph, of CRA, will provide a brief review of OCT technology, covering the technical aspects of OCT and potential issues that arise while interpreting data. We will dive into OCT output, how to correctly read OCT data findings, signal strength for reliability, and provide education of how to efficiently utilize OCT technology for treatment guidance of glaucoma and diseases of the retina, including AMD and diabetic retinopathy. We will also cover the anatomic measuring capabilities of the current devices in service as well as an overview of their normative database.

PRESENTERS
Murtaza Adam, MD, Peter Hovland, MD, PhD

Dr. Adam reviewed the many inherited, toxic, and idiopathic maculopathies that can mimic age-related macular degeneration (AMD) in the clinic.

Dr. Hovland wrapped up with content on surgical approaches for retinal detachments. He reviewed the types of retinal detachments there are, issues related to intraocular pressure, and special management of patients with retinal detachments who live at altitude.

PRESENTER
Murtaza Adam, MD

Protocols have changed significantly during the COVID-19 pandemic. Which of those procedures are here to stay and which will disappear as the pandemic subsides? NRR host John Kitchens, MD, invites Murtaza “Moo” Adam, MD; David R.P. Almeida, MD, PhD, MBA; and Christina Weng, MD, MBA, to discuss which changes implemented in 2020 will be permanent fixtures in retina practice. Watch the whole discussion back now! 

PRESENTERS
Murtaza Adam, MD & Salil Shukla, MD

Review of common and uncommon peripheral retinal findings found on routine funduscopic imaging and exams, including vitreous base pathology, vascular disease, neoplasms, degenerative disease, and variations of normal anatomy. Differential diagnoses, associated findings, and recommendations for management will be covered.